Adalta Capital Management’s Exelixis EXEL Stock Holding History

Adalta Capital Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,375	Closed	-$264K	–	85
2019 Q2	$264K	Buy	+12,375	New	+$259K	0.17%	70

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Adalta Capital Management's EXEL Position: Q3 2019 in Review

Adalta Capital Management sold out of Exelixis (EXEL) in Q3 2019, closing a stake of 12,375 shares — an estimated $264K sold.

Adalta Capital Management first reported a position in EXEL in Q2 2019 and held it in 1 quarter. The position peaked at $264K in Q2 2019. 339 funds tracked by Wall St. Rank hold EXEL as of Q3 2019.

Adalta Capital Management reported no remaining Exelixis position as of Q3 2019 after selling out during the quarter.
Adalta Capital Management sold 12,375 Exelixis shares in Q3 2019, an estimated $264K.
Adalta Capital Management first reported a position in Exelixis in Q2 2019 and held it in 1 quarter.
Adalta Capital Management's Exelixis position peaked at $264K in Q2 2019.
339 funds tracked by Wall St. Rank held Exelixis as of Q3 2019.

Based on Adalta Capital Management's 13F filing for Q3 2019, filed 15 Nov 2019.